Clinical trial · Interventional
Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities
Improving the Delivery of Effective Care to Minorities
NCT00145197CI-TRIAL-00012798completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine if a physician-centered intervention will help women with early stage breast cancer receive appropriate treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Improving the Delivery of Effective Care to Minorities | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Improving the Delivery of Effective Care to Minorities
- interventionNames
- Behavioral: Improving the Delivery of Effective Care to Minorities
Primary outcomes (1)
- measure
- initiation and completion of primary treatment
- timeFrame
- measured 6 months after patient recruitment
Secondary outcomes (4)
- measure
- adherence
- timeFrame
- measured at time of patient survey
- measure
- emotional and health status
- timeFrame
- measured at time of patient survey
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * All patients, who are English or Spanish speaking, with a new primary stage 1 or 2 breast cancer who have undergone either breast conserving surgery or mastectomy and those with tumors \> 1 cm or \< 1 cm and poorly differentiated * All surgeons performing breast surgery at the participating hospitals Exclusion Criteria: * Patients with dementia or those with a poor prognosis due to end-stage organ failure or other concomitant conditions such as those undergoing treatment for other cancers
References
Publications (0)
Data not yet available
No reference posted for this study.